Unaudited Supplemental Data | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
The following information is not a financial measure under generally accepted accounting principals (GAAP). In addition, it should not be construed as an |
alternative to any other measures of performance determined in accordance with GAAP, or as an indicator of our operating performance, liquidity or cash |
flows generated by operating, investing and financing activities as there may be significant factors or trends that it fails to address. We present this financial |
information because we believe that it is helpful to some investors as a measure of our operations. We caution investors that non-GAAP financial information, |
by its nature, departs from traditional accounting conventions; accordingly, its use can make it difficult to compare our results with our results from other |
reporting periods and with the results of other companies. | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Adjusted EBITDA Reconciliation | | Three months ended | | | Nine months ended | |
| | | | | September 30, 2012 | | September 30, 2011 | | September 30, 2012 | | September 30, 2011 |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Net income attributable to stockholders in accordance with GAAP | | $ | 3,388 | | | $ | 2,248 | | | $ | 14,311 | | | $ | 8,302 | |
| | | | | | | | | | | | | | | | | | | |
| Adjustments: | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | |
| | a. | | Stock based compensation expense | | | 2,087 | | | | 406 | | | | 4,922 | | | | 2,674 | |
| | b. | | Depreciation and amortization | | | 2,823 | | | | 2,400 | | | | 8,506 | | | | 3,463 | |
| | c. | | iFrogz acquisition expenses | | | - | | | | 119 | | | | - | | | | 1,947 | |
| | d. | | iFrogz inventory fair value write up | | | - | | | | 3,063 | | | | - | | | | 3,642 | |
| | e. | | Provision for income taxes | | | 1,958 | | | | 1,241 | | | | 8,684 | | | | 4,335 | |
| | f. | | Impairment of note receivable | | | - | | | | 1,071 | | | | - | | | | 1,071 | |
| | g. | | Other expense | | | 1,772 | | | | 1,273 | | | | 5,237 | | | | 1,433 | |
| | h. | | Noncontrolling interest | | | - | | | | (148 | ) | | | - | | | | (345 | ) |
| | | | | | | | | | | | | | | | | | | | |
Adjusted EBITDA | | $ | 12,028 | | | $ | 11,673 | | | $ | 41,660 | | | $ | 26,522 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP Reconciliation | | Three months ended | | | Nine months ended | |
| | | | | | September 30, 2012 | | September 30, 2011 | | September 30, 2012 | | September 30, 2011 |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Net income attributable to stockholders in accordance with GAAP | | $ | 3,388 | | | $ | 2,248 | | | $ | 14,311 | | | $ | 8,302 | |
| | | | | | | | | | | | | | | | | | | | |
| Adjustments: | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
| | a. | | Stock based compensation expense | | | 2,087 | | | | 406 | | | | 4,922 | | | | 2,674 | |
| | c. | | Depreciation and amortization | | | 2,823 | | | | 2,400 | | | | 8,506 | | | | 3,463 | |
| | d. | | iFrogz acquisition expenses | | | - | | | | 119 | | | | - | | | | 1,947 | |
| | e. | | iFrogz inventory fair value write up | | | - | | | | 3,063 | | | | - | | | | 3,642 | |
| | f. | | Impairment of note receivable | | | - | | | | 1,071 | | | | - | | | | 1,071 | |
| | g. | | Other expense | | | 1,772 | | | | 1,273 | | | | 5,237 | | | | 1,433 | |
| | h. | | Noncontrolling interest | | | - | | | | (148 | ) | | | - | | | | (345 | ) |
| | i. | | CEO departure expense | | | 910 | | | | - | | | | 910 | | | | - | |
| | j. | | Income tax effects | | | (2,781 | ) | | | (3,122 | ) | | | (7,392 | ) | | | (5,332 | ) |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP net income attributable to stockholders | | $ | 8,199 | | | $ | 7,310 | | | $ | 26,494 | | | $ | 16,855 | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP EPS attributable to stockholders | | $ | 0.26 | | | $ | 0.23 | | | $ | 0.84 | | | $ | 0.60 | |
| | | | | | | | | | | | | | | | | | | | |
Weighted average number of shares outstanding - diluted | | | 31,734 | | | | 31,375 | | | | 31,647 | | | | 28,308 | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP Reconciliation | | Three months ended | | | | | | | | | | | |
| | | | | | June 30, 2012 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Net income attributable to stockholders in accordance with GAAP | | $ | 5,812 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
| Adjustments: | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
| | a. | | Stock based compensation expense | | | 1,494 | | | | | | | | | | | | | |
| | b. | | Depreciation and amortization | | | 2,862 | | | | | | | | | | | | | |
| | c. | | Other expense | | | 1,235 | | | | | | | | | | | | | |
| | d. | | Income tax effects | | | (2,189 | ) | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP net income attributable to stockholders | | $ | 9,214 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Non-GAAP EPS attributable to stockholders | | $ | 0.29 | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Weighted average number of shares outstanding - diluted | | | 31,738 | | | | | | | | | | | | | |